참고문헌 (54)

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7. 

   상세보기

2. Marx RE, Sawatari Y, Fortin M, Broumand V. Biphosphonateinduced exposed bone (osteonecrosis/ostoepetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-75. 

   상세보기

3. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76. 

   상세보기

4. Kwon YD, Yoon BW, Walter C. Bisphosphonate, is it an emerging risk factor in oral surgery? J Korean Assoc Maxillofac Plast Reconstr Surg 2007;29:456-62. 

5. Park YD, Kim YR, Kim DY, Chung YS, Lee JK, Kim YG, et al. Awareness of Korean dentists on bisphosphonate related osteonecrosis of the jaws: preliminary report. J Korean Assoc Oral Maxillofac Surg 2009;35:153-7. 

6. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009;67(5 Suppl):2-12. 

   상세보기

7. The Korean Endocrine Society, the Korean Society of Bone Metabolism, the Korean Society of Osteoporosis, the Korean Association of Oral and Maxillofacial Surgeons. Bisphosphonate related osteonecrosis of the jaw (BRONJ): position statement of Korea. J Korean Endocr Soc 2009;24:227-30. 

   상세보기

8. Francis MD, Russell RG, Fleisch H. Diphosphonate inhibit formation of calcium phosphate crystals in vitro and pathological calcifications in vivo. Science 1969;165:1264-6. 

   상세보기

9. van Beek E, Pieterman E, Cohen L, Lo ¨wik C, Papapoulos S. Farnesyl pyrophosphate synthase is the molecular target of nitrogen containing bisphosphonates. Biochem Biophys Res Commun 1999;264:108-11. 

   상세보기

10. Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 2007;86:1022-33. 

    상세보기

11. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000;113:377-81. 

    상세보기

12. Fantasia JE. Bisphosphonates-what the dentist needs to know: practical consideration. J Oral Maxillofac Surg 2009;67(5 Suppl):53-60. 

13. Hillner BE, Ingle JN, Berenson JR, Janjan NA, Albain KS, Lipton A, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 2000;18:1378-91. 

    상세보기

14. Mehrotra B. Bisphosphonates-role in cancer therapies. J Oral Maxillofac Surg 2009;67(5 Suppl):19-26. 

    상세보기

15. Landesberg R, Eisig S, Fennoy I, Siris E. alternative indications for bisphosphonate therapy. J Oral Maxillofac Surg 2009;67(5 Suppl):27-34. 

16. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009;67(5 Suppl):61-70. 

17. Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 2007;1117:209-57. 

    상세보기

18. Garetto LP, Chen J, Parr JA, Roberts WE. Remodeling dynamics of bone supporting rigidly fixed titanium implants: a histomorphometric comparison in four species including humans. Implant Dent 1995;4:235-43. 

    상세보기

19. Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanism of bone loss. J Bone Miner Res 1997;12:498-508. 

    상세보기

20. Allen MR, Burr DB. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008;66:987-94. 

    상세보기

21. Lewiecki EM, Miller PD, McClung MR, Cohen SB, Bolognese MA, Liu Y, et al. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. J Bone Miner Res 2007;22:1832-41. 

    상세보기

22. Harper RP, Fung E. Resolution of bisphosphonate-associated osteonecosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 2007;65:573-80. 

    상세보기

23. Lau AN, Ali SH, Adachi JD. Resolution of osteonecosis of the jaw after teriparatide [recombinant human PTH (1-34)] therapy. Osteoporos Int 2008;19 Suppl 1:S80. 

24. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. J Periodontol 2007;78:584-94. 

    상세보기

25. Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, et al. Longterm effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res 2001;16:429-36. 

    상세보기

26. Peter CP, Cook WO, Nunamaker DM, Provost MT, Seedor JG, Rodan GA. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res 1996;14:74-9. 

    상세보기

27. Frost HM. In vivo osteocyte death. J Bone Joint Surg Am 1960;42A:138-43. 

28. Roelofs AJ, Coxon FP, Ebetino FH, Bala JF, Kashemirov BA, McKenna CE, et al. Use of a fluorescent analogue of risedronate to study localisation and cellular uptake of bisphosphonates in vivo. Bone 2008;42 Suppl 1:S85. 

29. Guise TA. Antitumor effects of bisphosphonates: promising preclinical evidence. Cancer Treat Rev 2008;34 Suppl 1:S19-24. 

    상세보기

30. Lipton A. Emerging role of bisphosphonates in the clinic-antitumor activity and prevention of metastasis to bone. Cancer Treat Rev 2008;34 Suppl 1:S25-30. 

    상세보기

31. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34. 

    상세보기

32. Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-61. 

    상세보기

33. Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G 3rd, Huryn JM. Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 2008;26:4037-8. 

    상세보기

34. Somerman MJ, McCauley LK. Bisphosphonates: sacrificing the jaw to save the skeleton? Bonekey Osteovision 2006;3:12-8. 

35. Lurie AG, Matteson SR. 99 M/Tc-diphosphonate bone imaging and uptake in healing rat extraction sockets. J Nucl Med 1976;17:688-92. 

36. McDougall IR. Skeletal scintigraphy. West J Med 1979;130:503-14. 

    상세보기

37. Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63:682-9. 

    상세보기

38. Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, et al. Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007;451:1009-17. 

    상세보기

39. Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, et al. Possible association between diabetes and bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 2007;92:1172-5. 

    상세보기

40. Wessel JH, Dodson TB, Zavras AI. Zoledronate, smoking and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study. J Oral Maxillofac Surg 2008;66:625-31. 

    상세보기

41. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005;23:8580-7. 

    상세보기

42. Hoff AO, Toth BB, Altundag K, Guarneri V, Adamus A, Nooka AK, et al. Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. ASCO Annual Meeting Proceedings (postmeeting edition). J Clin Oncol 2006;24(18 Suppl):8528. 

43. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaws and bisphosphonates. N Engl J Med 2005;353:99-102. 

    상세보기

44. -Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24:945-52. 

    상세보기

45. Sarasquete ME, Garcl'a-Sanz R, Marl'n L, Alcoceba M, Chillo'n MC, Balanzategui A, et al. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood 2008;112:2709-12. 

    상세보기

46. Krane SM. Death and taxes: glucocorticoids and Bone Cell Apoptosis. BoneKEy-Osteovision 2001;1:2001019. 

47. Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007;86:1013-21. 

    상세보기

48. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:433-41. 

    상세보기

49. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imagind findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009;67(5 Suppl):75-84. 

50. Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, et al. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res 2008;14:2387-95. 

    상세보기

51. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65:2397-410. 

    상세보기

52. Kunchur R, Need A, Hughes T. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 2010 68(2):487-8. 

    상세보기

53. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg 2010;38:255-9. 

    상세보기

54. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res 2009;20 Suppl 4:87-95. 

저자의 다른 논문 :

김여갑 (116) 이백수 (86) 권용대 (57) 서준호 (4)